SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Rigel Pharmaceuticals, Inc. (RIGL)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
566 39 0 RIGL
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
216Some publicity from over the pond: Telegraph: (Filed: 21/06/2004) Scientists mopgcw-6/28/2004
215I mean.... given your trickle efforts, it's not like you don't know hoscaram(o)uche-6/25/2004
214Why don't you just get past the urge, and apply to various grad schools? :-scaram(o)uche-6/25/2004
213[Targeting Syk as a treatment for allergic and autoimmune disorders] >>Extuck-6/25/2004
212gut tells me that they'll stop short of selling it all. great example of whscaram(o)uche-6/25/2004
211MPM starts the relentless selling again dribbling out...only 3.4 million more tomopgcw-6/25/2004
210That's not it at all. But any LONG post that starts with a citation to a 10keokalani'nui-6/14/2004
209What, you mean you don't read my long ramblings three times over? Excuse metuck-6/14/2004
208I did scan the thread headers before posting....sorry!keokalani'nui-6/14/2004
207after your admonition of Wilder..... >> Anybody got a read on interestingscaram(o)uche-6/14/2004
206Hey, pay attention! Message 20214360 Comments welcome. Cheers, Tucktuck-6/14/2004
205J Immunol. 2004 Jun 15;172(12):7324-34. Related Articles, Links A Novel Rolkeokalani'nui-6/14/2004
204And just when we were wondering what was happening with the ubiquitin ligase protuck-6/11/2004
203Rigel and Novartis initiated four programs, but the T and B cell programs seem ttuck-6/11/2004
202SignalsMag gives us a look at the details of Rigel's partnering deals, inclutuck-6/7/2004
201I think there might be a slight difference as the sellers here are alta/mpm/frazmopgcw-5/24/2004
200Ya know, I get about the same number of Form 4 alerts for RIGL as for VRTX. Reakeokalani'nui-5/24/2004
199Rigel Initiates Phase I/II Trial of R803 for the Treatment of Hepatitis C Virus mopgcw-5/24/2004
198Note 424b filed w/ Frazier and a bunch of small fry selling out 900,000+ shares.mopgcw-5/20/2004
197relentless: ALTA CALIFORNIA PARTNERS LP TITLE: Beneficial Owner DATE TRANSACTIOmopgcw-5/4/2004
196Rigel Announces First Quarter 2004 Financial Results Tuesday May 4, 7:31 am ET mopgcw-5/4/2004
195MPM and Alta continue to trickle out shares.. MPM BIOVENTURES III ,Ben. Owner,Smopgcw-4/27/2004
194My notes on the UL program are 2 years old. (!) They had it (one or more cpds) keokalani'nui-4/21/2004
193Old, but has a hint about another oncology target: the E3 ubiquitin ligase APC2/tuck-4/21/2004
192>>SOUTH SAN FRANCISCO, Calif., April 20 /PRNewswire-FirstCall/ -- Rigel Phtuck-4/20/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News